Market Exclusive

Analyst Activity – Cowen and Company Reiterates Outperform on GenMark Diagnostics (NASDAQ:GNMK)

Analyst Ratings For GenMark Diagnostics (NASDAQ:GNMK)

Today, Cowen and Company reiterated its Outperform rating on GenMark Diagnostics (NASDAQ:GNMK) with a price target of $17.00.

There are 4 buy ratings on the stock.

The current consensus rating on GenMark Diagnostics (NASDAQ:GNMK) is Buy (Score: 3.00) with a consensus target price of $17.00 per share, a potential 58.80% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For GenMark Diagnostics (NASDAQ:GNMK)
GenMark Diagnostics (NASDAQ:GNMK) has insider ownership of 7.50% and institutional ownership of 92.58%.

Recent Trading Activity for GenMark Diagnostics (NASDAQ:GNMK)
Shares of GenMark Diagnostics closed the previous trading session at 10.52 down -0.18 -1.73% with 3,119,052 shares trading hands.

Exit mobile version